Prof. Ron Dagan is a world renowned physician and researcher in the field of infectious diseases in children. His exceptional contribution in this field has won him both national and international recognition. Prof. Dagan has published over 450 original articles, reviews and book chapters and has presented more than 400 papers in national and international scientific conferences.
He graduated from The Hebrew University School of Medicine in Jerusalem and did his internship and pediatric residency at Soroka Medical Center. He has been a lecturer in the Faculty of Health Sciences at Ben-Gurion University of the Negev since its inception. He acquired his specialization in infectious diseases in children at Strong Medical Center at the University of Rochester, New York, USA. For the past 25 years Prof. Dagan has headed the Soroka Pediatric Infectious Disease Unit.
Prof. Dagan served as president of the European Society of Pediatric Infectious Diseases (ESPID) and later, in the World Society of Pediatric Infectious Diseases (WSPID). He is a member of scientific and medical societies as well as many advisory committees in Israel and abroad. He also advises the Israeli Ministry of Health on infectious diseases and is a member of the editorial board of several prestigious peer-reviewed scientific and medical journals.
He established a national advisory and treatment system for infectious diseases in children. He continues to contribute to developing and investigating vaccines and creating programs that greatly enhance the introduction of new vaccinations for routine use in Israel, as part of the nationally funded "basket of medications". He has concentrated his energies on a vaccine for Hepatitis A, a vaccine for Rotavirus and another for pneumococcus bacteria. He also has played an enormous role in better understanding and overcoming the antibiotic-resistant bacteria that cause infections in the respiratory and digestive tracts in children.
Prof. Dagan has been awarded many prestigious research grants and prizes, among them, the ESPID Bill Marshall Prize, the Israel Society of Microbiology Serov Prize for Excellence in Human Microbiology, the Samuel and Paula Elkeles Prize to an Outstanding Scientist in the Field of Medicine, and the Teva Founders Prize for advancing the treatment of infectious diseases in light of growing antibiotic resistance.